Zhejiang Starry Pharm Co Ltd (603520) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Zhejiang Starry Pharm Co Ltd (603520) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.76 Million ≈ $1.43 Million USD) by net assets (CN¥2.61 Billion ≈ $381.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Zhejiang Starry Pharm Co Ltd to measure how much of total assets are equity-financed.

Zhejiang Starry Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Starry Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Starry Pharm Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Starry Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Starry Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
China Railway Harbin Group of Technology Corp. A SHG:688459	N/A
Jinhe Biotechnology Co Ltd SHE:002688	0.088x
SAMPYO Cement Co. Ltd KQ:038500	0.061x
Shanghai New World Co Ltd SHG:600628	0.020x
Redwood Trust Inc NYSE:RWT	-4.710x
Telefonica Chile S.A. SN:CTC	-0.103x
Addnode Group AB (publ) ST:ANOD-B	0.123x
Allied Electronics Corporation Ltd JSE:AEL	0.163x

Annual Cash Flow Conversion Efficiency for Zhejiang Starry Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Starry Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Starry Pharm Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.56 Billion ≈ $375.23 Million	CN¥3.67 Million ≈ $536.56K	0.001x	-98.05%
2024-12-31	CN¥2.63 Billion ≈ $385.50 Million	CN¥193.50 Million ≈ $28.32 Million	0.073x	+180.09%
2023-12-31	CN¥1.76 Billion ≈ $257.38 Million	CN¥46.13 Million ≈ $6.75 Million	0.026x	+159.27%
2022-12-31	CN¥1.77 Billion ≈ $259.18 Million	CN¥-78.37 Million ≈ $-11.47 Million	-0.044x	-119.26%
2021-12-31	CN¥2.21 Billion ≈ $324.06 Million	CN¥508.84 Million ≈ $74.46 Million	0.230x	+145.57%
2020-12-31	CN¥1.86 Billion ≈ $272.87 Million	CN¥174.48 Million ≈ $25.53 Million	0.094x	-60.99%
2019-12-31	CN¥1.03 Billion ≈ $150.53 Million	CN¥246.77 Million ≈ $36.11 Million	0.240x	+15.41%
2018-12-31	CN¥922.96 Million ≈ $135.06 Million	CN¥191.84 Million ≈ $28.07 Million	0.208x	+901.60%
2017-12-31	CN¥872.44 Million ≈ $127.67 Million	CN¥18.10 Million ≈ $2.65 Million	0.021x	+123.47%
2016-12-31	CN¥827.01 Million ≈ $121.02 Million	CN¥7.68 Million ≈ $1.12 Million	0.009x	-95.52%
2015-12-31	CN¥457.70 Million ≈ $66.98 Million	CN¥94.88 Million ≈ $13.88 Million	0.207x	-37.79%
2014-12-31	CN¥432.13 Million ≈ $63.23 Million	CN¥144.00 Million ≈ $21.07 Million	0.333x	+71.57%
2013-12-31	CN¥386.11 Million ≈ $56.50 Million	CN¥74.99 Million ≈ $10.97 Million	0.194x	-36.70%
2012-12-31	CN¥336.81 Million ≈ $49.29 Million	CN¥103.34 Million ≈ $15.12 Million	0.307x	+325.46%
2011-12-31	CN¥301.81 Million ≈ $44.16 Million	CN¥-41.07 Million ≈ $-6.01 Million	-0.136x	--

About Zhejiang Starry Pharm Co Ltd

SHG:603520 China Drug Manufacturers - Specialty & Generic

Market Cap

$572.25 Million

CN¥3.91 Billion CNY

Market Cap Rank

#11518 Global

#3247 in China

Share Price

CN¥8.92

Change (1 day)

+0.56%

52-Week Range

CN¥8.00 - CN¥13.75

All Time High

CN¥651.92